Session Information

  • WCLC 2022

    2022 World Conference on Lung Cancer

    As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.

    Presentation Date(s):  
    • August 6 - 9, 2022
    • Total Presentations: 2015

    All times listed are in Vienna, Austria Time, CEST (UTC+2:00)

    PL - Plenary
    IBS - Interactive Breakfast Session (in-person attendees only)
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    P - Posters
    EP - ePosters
    WS - Workshops
    LA – Lectureship Awards
    IS - Industry Symposium

Filter Results:

Show Only CME Accredited Sessions

  • +

    MA01 - Molecular Subtypes and Prognostic Factors for SCLC and Neuroendocrine Tumors

    • 10:45 - 11:45
    • 8/07/2022
    • Location: Hall C7
    • Not for CME Credit
    • Type: Mini Oral
    • Track: Small Cell Lung Cancer and Neuro-Endocrine Tumors
    • +

      MA01.04 - Molecular Subtypes of Surgically Resected Small Cell Lung Cancer: Expression Pattern and Prognostic Relevance

      10:52 - 10:57  |  Presenter: Zsolt Megyesfalvi

      • Abstract

      Loading...

  • +

    EP07.01 - Mesothelioma, Thymoma, and Other Thoracic Malignancies - Clinical

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Mesothelioma, Thymoma, and Other Thoracic Malignancies - Clinical
    • +

      EP07.01-001 - Molecular Profiling Predicts Outcomes in Patients With Resected Malignant Pleural Mesothelioma

      Presenter: Christian Diego Rolfo

      • Abstract

      Loading...

  • +

    EP16.03 - Tumor Biology and Biomarkers - Molecular Profiling and Targeted Therapeutics

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Tumor Biology and Biomarkers - Molecular Profiling and Targeted Therapeutics
    • +

      EP16.03-029 - SLIT2 Expression in NSCLC With Long-Term Response to Pemetrexed

      Presenter: Eiji Nakajima

      • Abstract

      Loading...

  • +

    OA06 - Impact of COVID-19 on Cancer Management and Protection from Vaccines

    • 11:00 - 12:10
    • 8/08/2022
    • Location: Lehar 1
    • Not for CME Credit
    • Type: Oral
    • Track: Management of Lung Cancer in the Era of COVID-19
    • +

      OA06.03 - Serological Response to SARS-CoV-2 Vaccination in Patients Lung Cancer: A Mount Sinai-Led Prospective Matched Controlled Study

      11:02 - 11:12  |  Presenter: Philip C Mack

      • Abstract

      Loading...

  • +

    P2.12 - Tumor Biology and Biomarkers - Immune Biology & Immunotherapy

    • 17:15 - 19:15
    • 8/08/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: Regular Poster
    • Track: Tumor Biology and Biomarkers - Immune Biology & Immunotherapy
    • +

      P2.12-05 - Cancer and Atopy: Parallel Drivers? IL-4 Blockade Synergizes with PD-L1 Blockade to Reverse Type-2Mediated Immunosuppression

      Presenter: Thomas Urban Marron

      • Abstract

      Loading...

  • +

    P2.13 - Tumor Biology and Biomarkers - Minimally Invasive Biomarkers

    • 17:15 - 19:15
    • 8/08/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: Regular Poster
    • Track: Tumor Biology and Biomarkers - Minimally Invasive Biomarkers
    • +

      P2.13-01 - Low EV miR-30c Levels as Biomarker of Increased Tumor Autophagy and Chemoradiotherapy Resistance in Locally Advanced NSCLC

      Presenter: Diego de Miguel Perez

      • Abstract

      Loading...

  • +

    IBS17 - Interactive Debate: Predictive Biomarkers for Immunotherapy: Which Biomarker to Use across Histologies and Clinical Settings? (Ticketed Session) (In-person Access Only)

    • 07:30 - 08:15
    • 8/09/2022
    • Location: Lehar 3
    • IASLC CME Accredited
    • Type: Interactive Breakfast Session
    • Track: Tumor Biology and Biomarkers
    • +

      IBS17.01 - Interactive Debate: Predictive Biomarkers for Immunotherapy: Which Biomarker to Use across Histologies and Clinical Settings?

      07:30 - 07:45  |  Presenter: Fred R. Hirsch

      • Abstract

      Loading...